86 related articles for article (PubMed ID: 25683925)
1. The association between lysosomal protein glucocerebrosidase and Parkinson's disease.
Eur Rev Med Pharmacol Sci; 2015; 19(2):179. PubMed ID: 25683925
[No Abstract] [Full Text] [Related]
2. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
Wong YC; Krainc D
Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
[TBL] [Abstract][Full Text] [Related]
3. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
Barkhuizen M; Anderson DG; Grobler AF
Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
6. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations.
Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M
Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.
Parnetti L; Paciotti S; Eusebi P; Dardis A; Zampieri S; Chiasserini D; Tasegian A; Tambasco N; Bembi B; Calabresi P; Beccari T
Mov Disord; 2017 Oct; 32(10):1423-1431. PubMed ID: 28843015
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
Schmid SP; Schleicher ED; Cegan A; Deuschle C; Baur S; Hauser AK; Synofzik M; Srulijes K; Brockmann K; Berg D; Maetzler W
Mov Disord; 2012 Feb; 27(2):288-92. PubMed ID: 22021190
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients.
Papagiannakis N; Xilouri M; Koros C; Stamelou M; Antonelou R; Maniati M; Papadimitriou D; Moraitou M; Michelakakis H; Stefanis L
Mov Disord; 2015 Nov; 30(13):1830-4. PubMed ID: 26769460
[TBL] [Abstract][Full Text] [Related]
11. Progressive decline of glucocerebrosidase in aging and Parkinson's disease.
Rocha EM; Smith GA; Park E; Cao H; Brown E; Hallett P; Isacson O
Ann Clin Transl Neurol; 2015 Apr; 2(4):433-8. PubMed ID: 25909088
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease in patients and obligate carriers of Gaucher disease.
Becker JG; Pastores GM; Di Rocco A; Ferraris M; Graber JJ; Sathe S
Parkinsonism Relat Disord; 2013 Jan; 19(1):129-31. PubMed ID: 22940477
[TBL] [Abstract][Full Text] [Related]
13. Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease.
Rockenstein E; Clarke J; Viel C; Panarello N; Treleaven CM; Kim C; Spencer B; Adame A; Park H; Dodge JC; Cheng SH; Shihabuddin LS; Masliah E; Sardi SP
Hum Mol Genet; 2016 Jul; 25(13):2645-2660. PubMed ID: 27126635
[TBL] [Abstract][Full Text] [Related]
14. Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.
Sardi SP; Cheng SH; Shihabuddin LS
Prog Neurobiol; 2015 Feb; 125():47-62. PubMed ID: 25573151
[TBL] [Abstract][Full Text] [Related]
15. A feedforward loop links Gaucher and Parkinson's diseases?
Cookson MR
Cell; 2011 Jul; 146(1):9-11. PubMed ID: 21729776
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Aharon-Peretz J; Rosenbaum H; Gershoni-Baruch R
N Engl J Med; 2004 Nov; 351(19):1972-7. PubMed ID: 15525722
[TBL] [Abstract][Full Text] [Related]
17. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity.
Clark LN; Nicolai A; Afridi S; Harris J; Mejia-Santana H; Strug L; Cote LJ; Louis ED; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Mayeux R; Ottman R; Marder K
Mov Disord; 2005 Jan; 20(1):100-3. PubMed ID: 15517591
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
19. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
García-Sanz P; Orgaz L; Bueno-Gil G; Espadas I; Rodríguez-Traver E; Kulisevsky J; Gutierrez A; Dávila JC; González-Polo RA; Fuentes JM; Mir P; Vicario C; Moratalla R
Mov Disord; 2017 Oct; 32(10):1409-1422. PubMed ID: 28779532
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.
Zunke F; Andresen L; Wesseler S; Groth J; Arnold P; Rothaug M; Mazzulli JR; Krainc D; Blanz J; Saftig P; Schwake M
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3791-6. PubMed ID: 27001828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
